A phase III trial to investigate the efficacy and safety of MI-100 in patients with Stargardt's disease

Trial Profile

A phase III trial to investigate the efficacy and safety of MI-100 in patients with Stargardt's disease

Planning
Phase of Trial: Phase III

Latest Information Update: 04 May 2015

At a glance

  • Drugs Ecothiopate iodide (Primary)
  • Indications Stargardt disease
  • Focus Registrational; Therapeutic Use
  • Sponsors Makindus
  • Most Recent Events

    • 04 May 2015 According to a Makindus media release, Makindus recently met with the Food & Drug Administration (FDA) to review a clinical development program to evaluate MI-100 in a Phase 3 program which is plan to start by the end of this year.
    • 04 May 2015 According to a Makindus media release, planned initiation date changed from 1 Jan 2015 to 1 Dec 2015.
    • 22 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top